Drug Interaction Report

Sertraline and Ticagrelor: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Sertraline

No brand names on record
+

Ticagrelor

Brilinta
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 532 documented Sertraline interactions, 477 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Sertraline and ticagrelor together can add up to a higher bleeding risk, so watch for unusual bruising or bleeding and report it. Keep taking both as prescribed and let your care team monitor you.

You're taking sertraline (an antidepressant) along with ticagrelor (Brilinta, which helps keep your blood from clotting). Both of these can make bleeding a little more likely. Sertraline affects how your platelets, the cells that help you clot, use a chemical called serotonin. Ticagrelor already works by making platelets less sticky. Put together, they can add up.

This means you might bruise more easily or notice nosebleeds. Rarely, bleeding can be more serious. The good news is your care team can manage this by keeping an eye on you. Keep taking both as prescribed and let your doctor or pharmacist know if you notice unusual bruising or bleeding.

Effect: Additive bleeding risk with concurrent sertraline (SSRI) and ticagrelor (P2Y12 inhibitor).

  • Mechanism: Pharmacodynamic, not pharmacokinetic. SSRIs deplete platelet serotonin, impairing serotonin-mediated platelet aggregation; this adds to ticagrelor's antiplatelet effect on hemostasis.
  • Direction: Increased antiplatelet/bleeding effect (neither is a prodrug relevant here).
  • Evidence: Theoretical for this pair, though case-control/cohort data support increased bleeding with SSRI plus antiplatelet combinations.
  • Onset: Unspecified.
  • Management: Monitor for epistaxis, ecchymosis, hematoma, petechiae, and GI or major hemorrhage. Counsel patient on bleeding signs; dose/therapy individualized by the care team.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

An increased risk of bleeding

Interaction Deep Dive

Caution is advised when a SSRI is given together with an antiplatelet agent, since the combination may raise the likelihood of bleeding events32. Taking sertraline alongside an antiplatelet may heighten bleeding risk, an effect that may stem from the way sertraline influences serotonin release by platelets. Findings from case-control and cohort studies have linked the joint use of selective serotonin and norepinephrine reuptake inhibitors (sertraline among them) with antiplatelet agents to a greater bleeding risk. The bleeding events that have been documented include epistaxis, ecchymosis, hematoma, petechiae, and hemorrhages that are life-threatening. If sertraline and an antiplatelet agent are used at the same time, watch the patient for indications of increased bleeding and warn patients about the elevated bleeding risk1.

Why it happens (mechanism)

Release of serotonin by platelets; additive effects on hemostasis

How to manage this interaction

Keep taking both medications as prescribed unless your doctor tells you otherwise. This combination is manageable with awareness and monitoring.

  • Your care team may watch you more closely for signs of bleeding and may individualize your therapy if needed.
  • Watch for and report nosebleeds, easy bruising, small red skin spots, blood in urine or stool, black stools, or bleeding that won't stop.
  • Tell your pharmacist before adding NSAIDs (like ibuprofen), aspirin, or other blood thinners.
  • Bring up any concerns about bruising or bleeding with your pharmacist or prescriber.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

3 reports — tap to read

a) A retrospective study examined patients older than 50 years who were diagnosed with acute myocardial infarction (N=27,058). In this population, the combination of an SSRI with any antiplatelet therapy raised the bleeding risk significantly, by 1.42-fold, relative to aspirin alone. The regimen of aspirin, clopidogrel, and an SSRI raised the risk significantly by 2.35-fold compared with aspirin alone, and by 1.57-fold compared with combined clopidogrel and aspirin therapy 2.

b) In a systematic review and meta-analysis encompassing 22 observational studies, the use of SSRIs was linked to a significant 1.55-fold rise in the risk of upper gastrointestinal bleeding (UGIB). The combined use of SSRIs and antiplatelet agents was linked to a 2.48-fold rise in UGIB risk (3 studies) 3.

c) Case reports along with epidemiological investigations (case-control and cohort studies) have shown a link between the use of agents that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. Based on evidence from published observational studies, exposure to SSRIs, especially during the month prior to delivery, has been associated with a less than 2-fold increase in the risk of postpartum hemorrhage. Bleeding events associated with SSRIs and SNRIs have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.

Common questions

Can I take Sertraline and Ticagrelor together?

Sertraline and ticagrelor together can add up to a higher bleeding risk, so watch for unusual bruising or bleeding and report it. Keep taking both as prescribed and let your care team monitor you. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Sertraline and Ticagrelor interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Sertraline and Ticagrelor interaction managed?

Keep taking both medications as prescribed unless your doctor tells you otherwise. This combination is manageable with awareness and monitoring. Your care team may watch you more closely for signs of bleeding and may individualize your therapy if needed. Watch for and report nosebleeds, easy bruising, small red skin spots, blood in urine or stool, black stools, or bleeding that won't stop. Tell yo… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Sertraline or Ticagrelor need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (3)

  1. Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
  2. Labos C, Dasgupta K, Nedjar H, et al: Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ 2011; 183(16):1835-1843. PubMed
  3. Jiang HY, Chen HZ, Hu XJ, et al: Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2015; 13(1):42-50. PubMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.